ACM
GILD icon

Altrius Capital Management’s Gilead Sciences GILD Stock Holding History

Altrius Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
46,632
+1,321
+3% +$174K 1.12% 49
2026
Q1 		$6.32M Sell
45,311
-1,434
-3% -$201K 1.26% 38
2025
Q4 		$5.74M Sell
46,745
-1,373
-3% -$167K 1.22% 34
2025
Q3 		$5.34M Buy
48,118
+192
+0.4% +$21.8K 1.22% 37
2025
Q2 		$5.31M Buy
47,926
+154
+0.3% +$16.4K 1.24% 36
2025
Q1 		$5.35M Buy
47,772
+370
+0.8% +$38.2K 1.3% 34
2024
Q4 		$4.38M Sell
47,402
-15,005
-24% -$1.35M 1.18% 46
2024
Q3 		$5.23M Sell
62,407
-1,805
-3% -$138K 1.31% 32
2024
Q2 		$4.41M Buy
64,212
+11,232
+21% +$750K 1.16% 48
2024
Q1 		$3.88M Buy
52,980
+6,060
+13% +$466K 0.98% 64
2023
Q4 		$3.8M Buy
46,920
+58
+0.1% +$4.51K 1.06% 49
2023
Q3 		$3.51M Buy
46,862
+728
+2% +$56K 1.04% 44
2023
Q2 		$3.56M Buy
46,134
+200
+0.4% +$16K 1.05% 42
2023
Q1 		$3.81M Buy
45,934
+323
+0.7% +$26.8K 1.17% 30
2022
Q4 		$3.92M Sell
45,611
-1,457
-3% -$115K 1.23% 28
2022
Q3 		$2.9M Sell
47,068
-18,325
-28% -$1.16M 1.11% 43
2022
Q2 		$4.04M Buy
+65,393
New +$4.05M 1.31% 38

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Altrius Capital Management's GILD Position: Q2 2026 in Review

Altrius Capital Management increased its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, buying an estimated $174K and bringing the position to 46,632 shares worth $5.89M. The position accounts for 1.12% of the portfolio, ranked #49.

Altrius Capital Management first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.32M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Altrius Capital Management held 46,632 shares of Gilead Sciences worth $5.89M as of Q2 2026.
  • Altrius Capital Management bought 1,321 Gilead Sciences shares in Q2 2026, an estimated $174K.
  • Gilead Sciences made up 1.12% of Altrius Capital Management's portfolio in Q2 2026, its #49 holding.
  • Altrius Capital Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • Altrius Capital Management's Gilead Sciences position peaked at $6.32M in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Altrius Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.